The two diabetes-related Cochrane reviews published in October focused on diabetes during pregnancy; the first covered different methods of glucose monitoring, while the second compared oral antidiabetic agents with insulin, with both concluding that better quality research is needed to draw firm conclusions.
Metformin status at the time of initial dipeptidyl peptidase 4 inhibitor use may influence the effect these agents have on cardiovascular outcomes, be it positive or negative, suggest results of a hypothesis-generating meta-analysis.
With the arrival of slow-release formulations of metformin and the relaxation of guidelines concerning its use in patients with kidney disease, Carol Wysham explains how the population of patients who might benefit from this medication has expanded.
This chapter reviews the lessons learned from the Diabetes Prevention Program and the Action for Health in Diabetes studies regarding the health benefits of increasing physical activity in type 2 diabetes.
Gibbs BB, Jakicic JM. In: Diabetes and Exercise. Edited by Reusch JEB, Regensteiner JG, Stewart KJ, Veves A. Springer International Publishing AG, 2018. pp:175–184.